bioRxiv Science⌕ Search

Biology subjects

Bruzelius, A.

Publications and source records attributed to Bruzelius, A..

7 recordsLinked to original sources

Reconstruction of the human nigrostriatal pathway in vitro reveals target-dependent dopamine neuron maturation

The human nigrostriatal pathway, comprising dopaminergic neurons in the ventral midbrain (vMB) projecting to the dorsolateral striatum, is essential for motor control and selectively vulnerable in Parkinsons disease (PD). How this circuit assembles during development and how it degenerates under pathological conditions remains poorly understood in a human context and in vitro models capturing its long-range connectivity and spatial organization have been lacking. Here, we introduce the connectoid, a compartmentalized, human stem cell-based model of the nigrostriatal pathway that integrates vMB and striatal organoids within a custom-engineered microfluidic device, confining cell bodies while guiding axonal growth, mimicking the in vivo topography. Functional connectivity was confirmed by retrograde rabies tracing, and optogenetic and pharmacological stimulation, while 6-hydroxydopamine-induced selective degeneration of dopamine neurons, recapitulating a key feature of PD. Additionally, single-cell transcriptomics revealed that interaction with striatal targets enhances dopaminergic neuron maturation and activates transcriptional programs linked to synaptic signaling. Thus, connectoids uniquely allow spatial segregation of regionalized organoids while preserving long-range communication, providing a scalable and physiologically relevant platform for studying human circuit assembly, selective vulnerability, and therapeutic interventions in PD.

neuroscience↗

Cografting strategies uncover cell type dependent regulation of dopamine neuron specification and functional maturation in a pre clinical model of Parkinson`s Disease

Parkinsons disease (PD), the second most common neurodegenerative disorder, is characterized by the progressive loss of A9 dopaminergic neurons in the substantia nigra, leading to dopamine (DA) depletion in the striatum and subsequent motor symptoms. Transplantation of ventral midbrain-patterned DA (vmDA) progenitors derived from human pluripotent stem cells, aimed at restoring DA neurotransmission in the striatum, is being developed and currently explored in ongoing clinical trials. One factor that may improve the maturation and fate determination of DA neurons in vivo is the intercellular communication within the graft environment, ultimately affecting the therapeutic outcome. In this study, we co-transplanted vmDA progenitors with either glial, ventral forebrain or striatal progenitors into a preclinical xenograft PD model to investigate how these interactions shape the development, maturation, and function of therapeutic DA neurons. Our findings show that co-grafts with ventral forebrain progenitors increase the yield of DA neurons and also promote their functional maturation. Furthermore, we demonstrated that co-grafts with striatal neurons promote functional maturation and the acquisition of DA subtype identity. From these data, we identified EBF3 and PBX3 as candidate transcription factors directing DA neuron maturation and subtype specification, and then functionally validated their role in brain organoids. Taken together, our data highlight that the cellular microenvironment, including specific interactions with neighbouring cells, guides in vivo DA neuron specification and maturation. These findings provide a foundation for developing more refined and effective cell preparations for replacement therapy in PD, and define a conceptual framework that could inform stem cell-based strategies for other neurodegenerative diseases.

neuroscience↗

Long-lasting structural and functional maturation in transplanted human neurons reprogrammed from glial progenitor cells

Direct reprogramming of brain-resident glial progenitor cells (GPCs) into induced neurons (iN) shows great promise for future regenerative therapies for brain diseases. This type of cell conversion is facilitated by introducing lineage-specific transcription factors or small molecules to somatic cells, and can even be achieve in vivo, targeting resident glia cells in the brain for in vivo conversion. While this have shown promising results in animal models, a crucial step is to show the long-term survival and maturation of human reprogrammed cells in vivo. However, this remains largely unexplored partly due to the inaccessible cell source of GPC and difficulty in transplanting converted neurons. In this study, we assessed human GPCs derived iNs for their long-term structural and functional neuronal maturation after transplantation to the immunodeficient mouse brain. GPCs were transduced with established transcription factor cocktail and transplanted to the medial prefrontal cortex as three-dimensional cultures to improve survival and integration upon transplantation. Our results reveal survival of hiNs, for up to 10 months post-transplantation (MPT) and wide distribution across local and proximal functionally connected brain regions. Morphological analysis revealed a gradual neuronal maturation over time, characterized by increase in cellular complexity and expression of neuronal markers. Supporting these findings, electrophysiological recordings demonstrated progressive functional maturation up to 5 MPT with increase in sodium and potassium currents, and the ability to generate multiple evoked and spontaneous action potentials, validating a neuronal phenotype. Importantly, these changes were absent in control grafts of non-converted hGPCs that retained their glia identity. Our findings indicate that hGPCs derived iNs maintain a stable neuronal phenotype that persist in the mouse brain for extended periods. These cells exhibit survival and remarkable adaptability to the host environment, enabling both structural and functional maturation over time. These results highlight their potential as a promising strategy for neural replacement therapies aimed at restoring damaged circuits and promoting brain repair. Highlights* Human neurons reprogrammed from glia progenitor cells survive long term upon transplantation in the immunodeficient mouse brain. * The human induced neurons migrate to local and distal connected brain regions within prefrontal cortex circuitry. * Grafted neurons gradually develop neuronal complex morphology and electrophysiological functional properties in the mouse brain.

neuroscience↗

Non-neuronal, TGF-β- extracellular matrix restructuring promotes neurodegeneration in a PSP-Richardson syndrome model

Progressive supranuclear palsy-Richardson syndrome (PSP-RS) is a rapidly progressive tauopathy lacking effective therapies. Although tau aggregation is a defining feature, the initiating mechanisms remain elusive. Here we used patient-derived induced pluripotent stem cell midbrain organoids, integrating single-cell transcriptomics, bulk RNA profiling, and quantitative proteomics, to dissect early pathogenic events. We identified vascular leptomeningeal-like cells (VLMCs) as the first altered population, exhibiting TGF-{beta}-driven extracellular matrix (ECM) remodeling enriched in collagens, integrins, and TGFBI. The resulting pathological ECM increased stiffness, induced integrin clustering, and activated RhoA-ROCK-mediated cytoskeletal disorganization. These changes sustained PI3K-AKT and MAPK-ERK signaling, suppressed PP2A, hyperactivated mTOR, and impaired autophagy, culminating in tau hyperphosphorylation and mislocalization. Pharmacological inhibition of TGF-{beta}, AKT, ERK, or mTORC1 restored autophagic flux, reduced tau burden, and rescued neuronal architecture. Our findings establish non-neuronal, matrix-producing niche cells as upstream drivers of tauopathy and reveal TGF-{beta}-mediated ECM restructuring as a mechanochemical trigger of neurodegeneration, opening multiple therapeutic avenues for PSP-RS and related tauopathies.

neuroscience↗

Rapid and efficient generation of human oligodendrocytes myelinating adult human cortical neurons

Intracerebral transplantation of stem cell-derived oligodendrocytes (OLs) is a promising strategy for repairing demyelinated human brain tissue, the main hallmark of white-matter disorders. However, several challenges hinder clinical translation, including slow or inefficient production of human OLs with current protocols, and difficulty in generating pure OL grafts capable of remyelinating injured neural circuits. Here, we present a robust, highly reproducible method for the rapid and efficient production of human OLs from human induced pluripotent stem cell derived long-term neuroepithelial-like stem (lt-NES) cells. Induced expression of the lineage-defining transcription factors SOX10 and OLIG2 in lt-NES cells is sufficient to generate a population of 80% OLs within 7 days. Importantly, these cells survive, differentiate and form functional OL-exclusive grafts when transplanted into adult human brain slices ex vivo, constituting the first demonstration that an OL-exclusive graft with robust myelination capacity can be generated in a clinically relevant allogeneic environment. This advance marks a significant step towards the clinical application of oligodendrocyte replacement therapy for human demyelinating disorders.

neuroscience↗

Generating human parvalbumin interneurons through 3D glia reprogramming

Parvalbumin (PV) interneurons are crucial for synaptic plasticity, and their damage or loss is linked to various neurological disorders. Yet, generating these cells of human source in vitro is challenging, limiting advancements in cell repair and disease modelling. We introduce a novel approach to derive human PV neurons through direct reprogramming of glial precursor cells (GPCs). Using ectopic expression of GABAergic neuronal genes, GPCs efficiently convert into GABAergic interneurons in 3D culture environment within weeks and achieve functional neuronal maturity. Single-nuclei RNA sequencing identified a distinct PV neuronal cluster with high maturity and characteristics of PV chandelier subclass that are equivalent to bona fide human interneurons. Trajectory analysis revealed a distinct glia-to-PV interneuron conversion pathway, involving several new transitory genes, with potential for functional importance for PV derivation. Our data introduces a new strategy for generating human PV interneurons, promising significant implications for future generation of patient-specific PV neurons both in vitro and in vivo. HighlightsO_LIA novel approach to derive human PV interneurons by direct glia reprogramming. C_LIO_LIFirst comprehensive transcriptomic profiling of induced human PV interneurons. C_LIO_LIInduced PV interneurons are of chandelier subtype with transcriptional similarity to bona fide interneurons. C_LIO_LISuccessful glia-to-PV interneuron conversion passes through a specific reprogramming trajectory and involves key genes with functional potential. C_LI

neuroscience↗

Injectable 3D microcultures enable intracerebral transplantation of mature neurons directly reprogrammed from patient fibroblasts

Direct reprogramming of somatic cells into induced neurons (iNs) has become an attractive strategy for the generation of patient-specific neurons for disease modeling and regenerative neuroscience. To this end, adult human dermal fibroblasts (hDFs) present one of the most relevant cell sources. However, iNs generated from adult hDFs using two-dimensional (2D) cultures poorly survive transplantation into the adult brain in part due to the need for enzymatic or mechanical cellular dissociation before transplantation. Three-dimensional (3D) culturing methodologies have the potential to overcome these issues but have largely been unexplored for the purposes of direct neuronal reprogramming. Here we report a strategy for direct in vitro reprogramming of adult hDFs inside suspension 3D microculture arrays into induced DA neurospheroids (iDANoids). We show that iDANoids express neuronal and DA markers and are capable of firing mature action potentials and releasing dopamine. Importantly, they can be gently harvested and transplanted into the brain of a Parkinsons disease rat model to reproducibly generate functionally integrated neuron-rich grafts. The 3D culturing approach presented here thus eliminates a major bottleneck in direct neuronal reprogramming field and, due to its simplicity and versatility, could readily be adapted as a culturing platform used for a broad range of transplantation studies as well as disease modeling.

neuroscience↗